CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.82
+0.97 (19.94%)
At close: Jul 31, 2026, 4:00 PM EDT
5.60
-0.22 (-3.73%)
After-hours: Jul 31, 2026, 6:11 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $8.5 million as of July 31, 2026. Its market cap has increased by 110.57% in one year.
Market Cap
8.50M
Enterprise Value
5.78M
1-Year Change
110.57%
Ranking
Category
Stock Price
$5.82
ChartMarket Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $8.50M, a decrease of -87.84%. That is a compound annual growth rate of -26.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 8.50M | 161.05% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 9.64M |
| BioCardia | 9.38M |
| Lisata Therapeutics | 9.02M |
| Quoin Pharmaceuticals | 8.94M |
| Lunai Bioworks | 8.80M |
| Aspire Biopharma Holdings | 8.44M |
| Immuron | 8.25M |
| Niki BioSolutions | 8.04M |